외래환자 대상 당뇨병 약료서비스 모델 개발

키워드

참고문헌 (37)

1. Hepler CD, "Opportunity and responsibility in pharmaceutical care", Am J Hosp Pharm, 47, pp.533~543 (1990)
2. Hammond RW, "Collaborative drug therapy management by pharmacist-2003", Pharmacotherapy, 23, pp.1210~1225 (2003)
3. Bond CA, "Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals", Pharmacotherapy, 26, pp.735~747 (2006)
4. Bond CA, "Clinical and economic outcomes of pharmacist-managed antiepileptic drug therapy", Pharmacotherapy, 26, pp.369~378 (2006)
5. Gray DR, "Cost-justification of a clinical pharmacist-managed anticoagulation clinic", Drug Intell Clin Pharm, 19, pp.575~580 (1985)
6. McGivney MS, "Medication therapy management: Its relationship to patient counseling, disease management, and pharmaceutical care", J Am Pharm Assoc, 47, pp.620~628 (2007)
7. American Pharmacists Association, "Medication management therapy in pharmacy practice: Core elements of an MTM service model (version 2.0)", J Am Pharm Assoc, 48, pp.341~353 (2008)
8. McBane SE, "Collaborative drug therapy management and comprehensive medcation manangement-2015", Pharmacotherapy, 35, pp.e39~e50 (2015)
9. Bluml BM, "Definition of medication therapy manangement: development of professionwide consensus", J Am Pharm. Assoc, 45, pp.566~572 (2005)
10. American College of Clinical Pharmacy (ACCP)., "Standards of practice for clinical pharmacists", Pharmacotherapy, 34, pp.794~797 (2014)
11. Duckworth W, "VADT Investigators. Glucose control and vascular complications in verterans with type 2 diabetes", N Engl J Med, 360, pp.129~139 (2009)
12. Patel A, "ADVANCE Collaborative Group. Intesive blood glucose control and vascular outcomes in patients with type 2 diabetes", N Engl J Med, 358, pp.2560~2572 (2008)
13. Gerstein HC, "Action to Control Cardiovascular Risk in Diabetes Study Group. Effect of intensive glucose lowering in type 2 diabetes", N Engl J Med, 358, pp.2545~2559 (2008)
14. Al Mazroui NR, "Influence of pharmaceutical care on health outcomes in patients with type 2 diabetes mellitus", Br J Clin Pharmacol, 67, pp.547~557 (2009)
15. Chan CW, "A pharmacist care program : positive impact on cardiac risk in patients with type 2 diabetes", J Cardiovasc Pharmacol Ther, 17, pp.57~64 (2012)
16. Choe HM, "Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist : a randomized controlled trial", Am J Manag Care, 11, pp.253~260 (2005)
17. Chung WW, "Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes", Patient Prefer Adherence, 8, pp.1185~1194 (2014)
18. Clifford RM, "Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes : the Fremantle Diabetes Study", Diabetes Care, 28, pp.771~776 (2005)
19. Cohen LB, "Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes", Diabetes Educ, 37, pp.801~812 (2011)
20. Farsaei S, "Effect of pharmacist-led patient education on glycemic control of type 2 diabetics : a randomized controlled trial", J Res Med Sci, 16, pp.43~49 (2011)
21. Jarab AS, "Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan", J Manag Care Pharm, 18, pp.516~526 (2012)
22. Mahwi TO, "Role of the pharmaceutical care in the management of patients with type 2 diabetes mellitus", Int J Pharm Sci Res, 4, pp.1363~1369 (2013)
23. Mourao AO, "Pharmaceutical care program for type 2 diabetes patients in Brazil : a randomised controlled trial", Int J Clin Pharm, 35, pp.79~86 (2013)
24. Rothman RL, "A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes", Am J Med, 118, pp.276~284 (2005)
25. Scott DM, "Outcomes of pharmacist-managed diabetes care services in a community health center", Am J Health Syst Pharm, 63, pp.2116~2122 (2006)
26. Simpson SH, "Effect of adding pharmacists to primary care teams on blood pressure control in patients with type 2 diabetes : a randomized controlled trial", Diabetes Care, 34, pp.20~26 (2011)
27. Sriram S, "Impact of pharmaceutical care on quality of life in patients with type 2 diabetes mellitus", J Res Med Sci, 16(Suppl 1), pp.S412~S418 (2011)
28. Wishah RA, "Impact of pharmaceutical care interventions on glycemic control and other health-related clinical outcomes in patients with type 2 diabetes : randomized controlled trial", Diabetes Metab Syndr, 9, pp.271~276 (2015)
29. Plaster CP, "Reduction of cardiovascular risk in patients with metabolic syndrome in a community health center after a pharmaceutical care program of pharmacotherapy follow-up", Braz J Pharm Sci, 48, pp.435~446 (2012)
30. Malathy R, "Effect of a diabetes counseling programme on knowledge, attitude and practice among diabetic patients in Erode district of South India", J Young Pharm, 3, pp.65~72 (2011)
31. "Diabetes Fact Sheet in Korean 2016"[URL]
32. Smith MA, "Pharmacotherapy Self-Assessment Program 7th ed. Science and practice of pharmacotherapy", pp.87~102 (2011), American College of Clinical Pharmacy
33. "MedicalTimes News. 2014-10-15"[URL]
34. Nichols-English G, "Optimizing adherence to pharmaceutical care plans", J Am Pharm Assoc, 40, pp.475~485 (2012)
35. Conrad P, "The meaning of medications: Another look at compliance", Soc Sci Med, 20, pp.29~37 (1985)
36. Monte SV, "Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model", J Am Pharm Assoc, 49, pp.200~208 (2009)
37. Cranor CW, "The Asheville Project : Long-term clijncial and economic outcomes of a community pharmacy diabetes care program", J Am Pharm Assoc, 43, pp.173~184 (2003)

관련 논문AI추천